U.S. Physical Therapy (NYSE:USPH – Get Free Report) issued its quarterly earnings data on Tuesday. The company reported $0.51 earnings per share for the quarter, missing the consensus estimate of $0.58 by ($0.07), Briefing.com reports. U.S. Physical Therapy had a return on equity of 8.52% and a net margin of 4.67%. The business had revenue of $155.70 million during the quarter, compared to analyst estimates of $153.30 million. During the same quarter last year, the firm earned $0.59 EPS. U.S. Physical Therapy’s revenue for the quarter was up 4.8% compared to the same quarter last year.
U.S. Physical Therapy Price Performance
Shares of USPH stock opened at $103.93 on Thursday. The business has a fifty day simple moving average of $105.34 and a 200 day simple moving average of $96.37. The company has a market cap of $1.57 billion, a P/E ratio of 76.99, a P/E/G ratio of 4.99 and a beta of 1.39. The company has a quick ratio of 2.28, a current ratio of 2.28 and a debt-to-equity ratio of 0.29. U.S. Physical Therapy has a twelve month low of $78.08 and a twelve month high of $124.11.
U.S. Physical Therapy Increases Dividend
The firm also recently declared a quarterly dividend, which was paid on Friday, April 5th. Stockholders of record on Tuesday, March 12th were issued a dividend of $0.44 per share. The ex-dividend date was Monday, March 11th. This represents a $1.76 dividend on an annualized basis and a dividend yield of 1.69%. This is a boost from U.S. Physical Therapy’s previous quarterly dividend of $0.43. U.S. Physical Therapy’s payout ratio is 130.37%.
Insider Buying and Selling at U.S. Physical Therapy
Analyst Upgrades and Downgrades
A number of equities analysts have commented on USPH shares. StockNews.com upgraded U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research note on Monday, March 18th. Barrington Research raised their price target on U.S. Physical Therapy from $120.00 to $122.00 and gave the stock an “outperform” rating in a research report on Friday, March 1st. Finally, JPMorgan Chase & Co. upped their price objective on shares of U.S. Physical Therapy from $99.00 to $117.00 and gave the stock an “overweight” rating in a research report on Wednesday, March 13th. One analyst has rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $125.67.
View Our Latest Analysis on USPH
About U.S. Physical Therapy
U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.
See Also
- Five stocks we like better than U.S. Physical Therapy
- Pros And Cons Of Monthly Dividend Stocks
- How to Bet on a Large Stock Price Move with an Options Strangle
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Shopify Stock Took a Breather, Markets Stay Bullish On its Future
- Financial Services Stocks Investing
- No New Highs for Cloudflare in 2024
Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.